Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
This grant opportunity supports clinical trials for rare neurodegenerative diseases that currently lack adequate treatment options. The trials should focus on assessing the safety and effectiveness of medical products to either introduce a new usage or modify existing labeling. The FDA encourages using innovative trial designs to speed up drug development.
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
Notice of Funding Opportunity (NOFO) for Clinical Trials of Orphan Products
National Institutes of Health
-
Efficient and Innovative Natural History Studies for Rare Diseases
National Institutes of Health
-
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
National Institutes of Health ▸ National Institute of Mental Health
-
NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)
National Institutes of Health
-
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers